Latest Period
Q4 2025
Security Snapshot
Evolus, Inc. - Common Stock (EOLS) Institutional Ownership
CUSIP: 30052C107
13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026
Institutions Reporting
168
Shares (Excl. Options)
49,021,799
Price
$6.65
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock
- Symbol
- EOLS on Nasdaq
- Shares outstanding
- 64,879,792
- Price per share
- $4.33
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 49,021,799
- Total reported value
- $326,014,392
- % of total 13F portfolios
- 0%
- Share change
- -6,708,624
- Value change
- -$41,089,898
- Number of holders
- 168
- Price from insider filings
- $4.33
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- EOLS - Evolus, Inc. - Common Stock is tracked under CUSIP 30052C107.
- 168 institutions reported positions in Q4 2025.
- 6 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 168 to 26 between Q4 2025 and Q1 2026.
- Reported value moved from $326,014,392 to $8,378,557.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 168 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 30052C107?
CUSIP 30052C107 identifies EOLS - Evolus, Inc. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 30052C107:
Significant Owners of Evolus, Inc. - Common Stock (EOLS) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| LYNCH TIMOTHY P | 9.9% | +25% | $36,305,352 | +$7,299,518 | 6,425,726 | +25% | Timothy P. Lynch | 31 Dec 2025 |
| Nantahala Capital Management, LLC | 8.8% | +49% | $35,162,902 | +$12,129,656 | 5,726,857 | +53% | Nantahala Capital Management, LLC | 30 Sep 2025 |
| BlackRock, Inc. | 6.9% | $50,851,038 | 4,364,896 | BlackRock, Inc. | 31 Dec 2024 | |||
| PERCEPTIVE ADVISORS LLC | 3.8% | -43% | $23,461,512 | -$15,682,755 | 2,474,843 | -40% | Perceptive Advisors LLC | 30 Jun 2025 |
| Medytox Inc. | 3.4% | $24,889,631 | 2,136,449 | Medytox Inc. | 31 Dec 2024 | |||
| TANG CAPITAL MANAGEMENT LLC | 1.9% | -75% | $7,038,160 | -$21,197,145 | 1,245,692 | -75% | TANG CAPITAL MANAGEMENT, LLC | 31 Dec 2025 |
As of 31 Dec 2025, 168 institutional investors reported holding 49,021,799 shares of Evolus, Inc. - Common Stock (EOLS). This represents 76% of the company’s total 64,879,792 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Evolus, Inc. - Common Stock (EOLS) together control 62% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 9% | 5,820,649 | +1.6% | 2.3% | $38,707,316 |
| BlackRock, Inc. | 6.3% | 4,095,300 | -8.5% | 0% | $27,233,746 |
| VANGUARD GROUP INC | 5.2% | 3,341,804 | -2.5% | 0% | $22,222,997 |
| BRAIDWELL LP | 4.8% | 3,105,209 | 0.66% | $20,649,640 | |
| Frazier Life Sciences Management, L.P. | 4.1% | 2,630,665 | 0% | 0.47% | $17,493,922 |
| MILLENNIUM MANAGEMENT LLC | 3.2% | 2,093,037 | +13% | 0.01% | $13,918,696 |
| Stonepine Capital Management, LLC | 2.5% | 1,631,588 | +6.2% | 8.6% | $10,850,060 |
| STATE STREET CORP | 2.4% | 1,574,851 | +3.9% | 0% | $10,472,759 |
| D. E. Shaw & Co., Inc. | 2.4% | 1,541,096 | +14% | 0.01% | $10,248,288 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.1% | 1,386,248 | -2.2% | 0% | $9,221,169 |
| CITADEL ADVISORS LLC | 2.1% | 1,379,131 | +134% | 0.01% | $9,171,221 |
| TANG CAPITAL MANAGEMENT LLC | 1.9% | 1,245,692 | -77% | 0.41% | $8,283,852 |
| RICE HALL JAMES & ASSOCIATES, LLC | 1.8% | 1,153,444 | -1.3% | 0.42% | $7,670,403 |
| Soleus Capital Management, L.P. | 1.6% | 1,070,000 | -26% | 0.3% | $7,115,500 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 1.5% | 986,466 | -2.8% | 0% | $6,579,728 |
| ARMISTICE CAPITAL, LLC | 1.5% | 976,000 | 0.16% | $6,490,400 | |
| UBS Group AG | 1.4% | 881,369 | -14% | 0% | $5,861,104 |
| RENAISSANCE TECHNOLOGIES LLC | 1.2% | 799,900 | +28% | 0.01% | $5,319,335 |
| PINNACLE ASSOCIATES LTD | 1.2% | 782,365 | +16% | 0.07% | $5,202,727 |
| Buckley Capital Advisors, LLC | 1.1% | 744,242 | 0% | 4.3% | $4,949,209 |
| MORGAN STANLEY | 1.1% | 730,664 | +175% | 0% | $4,858,916 |
| EcoR1 Capital, LLC | 1% | 675,000 | 0.21% | $4,488,750 | |
| Soviero Asset Management, LP | 1% | 655,000 | +98% | 2.3% | $4,355,750 |
| AWH Capital, L.P. | 0.96% | 625,000 | 0% | 3.8% | $4,156,250 |
| BNP PARIBAS FINANCIAL MARKETS | 0.87% | 564,988 | 0% | 0% | $3,757,170 |
Institutional Holders of Evolus, Inc. - Common Stock (EOLS) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 2,038,345 | $8,378,557 | +$2,464,866 | $4.11 | 26 |
| 2025 Q4 | 49,021,799 | $326,014,392 | -$41,089,898 | $6.65 | 168 |
| 2025 Q3 | 54,269,920 | $333,221,285 | -$49,039,353 | $6.14 | 158 |
| 2025 Q2 | 58,306,002 | $536,933,982 | +$27,282,114 | $9.21 | 171 |
| 2025 Q1 | 54,269,937 | $652,886,328 | +$25,547,799 | $12.03 | 178 |
| 2024 Q4 | 51,921,808 | $573,114,520 | +$6,665,899 | $11.04 | 164 |
| 2024 Q3 | 50,293,278 | $814,501,081 | -$14,779,328 | $16.20 | 164 |
| 2024 Q2 | 51,340,763 | $557,051,494 | +$21,839,886 | $10.85 | 155 |
| 2024 Q1 | 49,347,816 | $690,868,493 | +$53,544,087 | $14.00 | 160 |
| 2023 Q4 | 45,541,929 | $479,552,344 | +$47,465,780 | $10.53 | 149 |
| 2023 Q3 | 41,447,331 | $378,821,815 | +$40,085,326 | $9.14 | 135 |
| 2023 Q2 | 37,278,540 | $271,085,912 | +$16,634,153 | $7.27 | 132 |
| 2023 Q1 | 34,126,762 | $288,714,148 | +$41,941,872 | $8.46 | 124 |
| 2022 Q4 | 29,273,655 | $219,845,469 | +$14,363,180 | $7.51 | 116 |
| 2022 Q3 | 25,565,680 | $205,795,765 | -$5,087,386 | $8.05 | 122 |
| 2022 Q2 | 25,348,901 | $294,043,424 | +$27,306,633 | $11.60 | 117 |
| 2022 Q1 | 23,065,245 | $258,202,339 | +$27,115,832 | $11.22 | 115 |
| 2021 Q4 | 20,576,998 | $133,137,102 | +$16,160,367 | $6.51 | 102 |
| 2021 Q3 | 17,623,312 | $134,773,188 | +$2,126,205 | $7.62 | 109 |
| 2021 Q2 | 16,226,875 | $205,283,641 | +$96,350,898 | $12.65 | 111 |
| 2021 Q1 | 8,608,655 | $111,825,892 | +$19,807,970 | $12.99 | 92 |
| 2020 Q4 | 7,776,423 | $26,127,429 | +$1,508,358 | $3.36 | 79 |
| 2020 Q3 | 7,265,841 | $28,771,905 | -$11,631,486 | $3.91 | 77 |
| 2020 Q2 | 9,284,051 | $49,207,493 | -$20,294,810 | $5.30 | 80 |
| 2020 Q1 | 14,269,284 | $58,934,912 | -$12,174,946 | $4.15 | 95 |
| 2019 Q4 | 13,995,058 | $170,310,558 | +$99,390,874 | $12.17 | 101 |
| 2019 Q3 | 5,663,928 | $88,460,159 | +$6,453,980 | $15.62 | 92 |
| 2019 Q2 | 5,294,303 | $77,402,817 | +$17,407,129 | $14.62 | 103 |
| 2019 Q1 | 3,901,128 | $88,035,182 | -$2,688,589 | $22.57 | 90 |
| 2018 Q4 | 5,405,565 | $64,325,153 | -$25,490,499 | $11.90 | 72 |
| 2018 Q3 | 6,656,409 | $123,935,961 | +$57,861,875 | $18.62 | 68 |
| 2018 Q2 | 3,521,598 | $98,567,769 | +$802,066 | $27.99 | 54 |
| 2018 Q1 | 4,445,338 | $40,139,664 | +$40,139,664 | $9.03 | 39 |
| 2016 Q2 | 0 | $0 | -$286,000 | $4.33 | 0 |
| 2016 Q1 | 12,761 | $286,000 | $22.41 | 1 |